Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Polak, Marta E ^a,b   Ung, Chuin Ying ^a   Masapust, Joanna ^a   Freeman, Tom C ^c   Ardern Jones, Michael R ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON REGULATORY FACTOR;

BIOLOGICAL MODEL; BIOLOGY; CELL MOTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; HUMAN; IMMUNOLOGY; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; METABOLISM; PROCEDURES; T LYMPHOCYTE;

CELL MOVEMENT; COMPUTATIONAL BIOLOGY; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; INTERFERON REGULATORY FACTORS; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; T-LYMPHOCYTES;

EID: 85018788594     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00651-5     Document Type: Article

References (88)

1. Newell, L., et al. Sensitization via Healthy Skin Programs Th2 Responses in Individuals with Atopic Dermatitis. J Invest Dermatol 133, 2372-2380, doi:10.1038/jid.2013.148 (2013).
2. Polak, M. E., et al. Distinct molecular signature of human skin langerhans cells denotes critical differences in cutaneous dendritic cell immune regulation. J Invest Dermatol 134, 695-703, doi:10.1038/jid.2013.375 (2014).
3. Polak, M. E., et al. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells. J Invest Dermatol 132, 1636-1644, doi:10.1038/jid.2012.26 (2012).
4. Seneschal, J., Clark, R. A., Gehad, A., Baecher-Allan, C. M., Kupper, T. S. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36, 873-884, doi:10.1016/j.immuni.2012.03.018 (2012).
5. van der Aar, A. M., et al. Langerhans Cells Favor Skin Flora Tolerance through Limited Presentation of Bacterial Antigens and Induction of Regulatory T Cells. J Invest Dermatol 133, 1240-1249, doi:10.1038/jid.2012.500 (2013).
6. Beck, L. A., et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 124, 260-269, 269 e261-267, doi:10.1016/j.jaci.2009.05.020 (2009).
7. Peng, W. M., et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 127, 1261-1263, doi:10.1038/sj.jid.5700657 (2007).
8. Gao, P. S., et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol 124, 507-513, 513 e501-507, doi:10.1016/j.jaci.2009.07.034 (2009).
9. Leung, D. Y., et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol 127, 965-973 e961-965, doi:10.1016/j.jaci.2011.02.010 (2011).
10. Scott, J. E., et al. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation. J Allergy Clin Immunol 120, 1382-1388, doi:10.1016/j.jaci.2007.08.004 (2007).
11. Mathias, R. A., et al. Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferongamma-producing CD8+ T cells. Br J Dermatol 169, 700-703, doi:10.1111/bjd.12382 (2013).
12. Staudacher, A., Hinz, T., Novak, N., von Bubnoff, D., Bieber, T. Exaggerated IDO1 expression and activity in Langerhans cells from patients with atopic dermatitis upon viral stimulation: A potential predictive biomarker for high risk of Eczema herpeticum. Allergy. doi:10.1111/all.12699 (2015).
13. Banchereau, J., et al. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming. Blood 119, 5742-5749, doi:10.1182/blood-2011-08-371245 (2012).
14. Ebner, S., et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol 119, 982-990, doi:10.1016/j.jaci.2007.01.003 (2007).
15. Soumelis, V., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3, 673-680, doi:10.1038/ni805 (2002).
16. Fujita, H., et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol 128, 574-582 e571-512, doi:10.1016/j.jaci.2011.05.016 (2011).
17. Mabbott, N. A., Baillie, J. K., Brown, H., Freeman, T. C., Hume, D. A. An expression atlas of human primary cells: Inference of gene function from coexpression networks. BMC Genomics 14, 632, doi:10.1186/1471-2164-14-632 (2013).
18. Xue, J., et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288, doi:10.1016/j.immuni.2014.01.006 (2014).
19. Amit, I., et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science (New York, N.Y.) 326, 257-263, doi:10.1126/science.1179050 (2009).
20. Loriaux, P. M., Hoffmann, A. A framework for modeling the relationship between cellular steady-state and stimulusresponsiveness. Methods Cell Biol 110, 81-109, doi:10.1016/b978-0-12-388403-9.00004-7 (2012).
21. Tian, Z., Faure, A., Mori, H., Matsuno, H. Identification of key regulators in glycogen utilization in E. coli based on the simulations from a hybrid functional Petri net model. BMC Syst Biol 7 (Suppl 6), S1, doi:10.1186/1752-0509-7-s6-s1 (2013).
22. Shih, V. F., et al. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-kappaB pathways. Nat Immunol 13, 1162-1170, doi:10.1038/ni.2446 (2012).
23. Laslo, P., Pongubala, J. M., Lancki, D. W., Singh, H. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin Immunol 20, 228-235, doi:10.1016/j.smim.2008.08.003 (2008).
24. Ruths, D., Muller, M., Tseng, J. T., Nakhleh, L., Ram, P. T. The signaling petri net-based simulator: A non-parametric strategy for characterizing the dynamics of cell-specific signaling networks. PLoS Comput Biol 4, e1000005, doi:10.1371/journal.pcbi.1000005 (2008).
25. Steggles, L. J., Banks, R., Shaw, O., Wipat, A. Qualitatively modelling and analysing genetic regulatory networks: A Petri net approach. Bioinformatics (Oxford, England) 23, 336-343, doi:10.1093/bioinformatics/btl596 (2007).
26. Roy, S., et al. Batf2/Irf1 Induces Inflammatory Responses in Classically Activated Macrophages, Lipopolysaccharides, Mycobacterial Infection. J Immunol 194, 6035-6044, doi:10.4049/jimmunol.1402521 (2015).
27. Marecki, S., Riendeau, C. J., Liang, M. D., Fenton, M. J. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J Immunol 166, 6829-6838 (2001).
28. Liu, J., Guan, X., Tamura, T., Ozato, K., Ma, X. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem 279, 55609-55617, doi:10.1074/jbc. M406565200 (2004).
29. Williams, J. W., et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nature communications 4, 2990, doi:10.1038/ncomms3990 (2013).
30. Ahyi, A. N., Chang, H. C., Dent, A. L., Nutt, S. L., Kaplan, M. H. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J Immunol 183, 1598-1606, doi:10.4049/jimmunol.0803302 (2009).
31. Tussiwand, R., et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity 42, 916-928, doi:10.1016/j.immuni.2015.04.017 (2015).
32. Glasmacher, E., et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science (New York, N.Y.) 338, 975-980, doi:10.1126/science.1228309 (2012).
33. Shi, L., Perin, J. C., Leipzig, J., Zhang, Z., Sullivan, K. E. Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes. Gene 487, 21-28, doi:10.1016/j.gene.2011.07.004 (2011).
34. Gabriele, L., et al. IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J Leukoc Biol 80, 1500-1511, doi:10.1189/jlb.0406246 (2006).
35. Masumi, A., Tamaoki, S., Wang, I. M., Ozato, K., Komuro, K. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett 531, 348-353 (2002).
36. Aryee, M. J., Gutierrez-Pabello, J. A., Kramnik, I., Maiti, T., Quackenbush, J. An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation). BMC Bioinformatics 10, 409, doi:10.1186/1471-2105-10-409 (2009).
37. Conesa, A., Nueda, M. J., Ferrer, A., Talon, M. maSigPro: A method to identify significantly differential expression profiles in timecourse microarray experiments. Bioinformatics (Oxford, England) 22, 1096-1102, doi:10.1093/bioinformatics/btl056 (2006).
38. Freeman, T. C., et al. Construction, visualisation, clustering of transcription networks from microarray expression data. PLoS Comput Biol 3, 2032-2042, doi:10.1371/journal.pcbi.0030206 (2007).
39. Enright, A. J., Van Dongen S F-O, C. A., Ouzounis, C. A. An efficient algorithm for large-scale detection of protein families. doi: D-NLM: PMC101833 EDAT-2002/03/28 10:00 MHDA-2002/05/04 10:01 CRDT-2002/03/28 10:00 PST-ppublish (2002).
40. Chen, J., Bardes, E. E., Aronow, B. J., Jegga, A. G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37, W305-W311, doi:10.1093/nar/gkp427 (2009).
41. Singh, H., Khan, A. A., Dinner, A. R. Gene regulatory networks in the immune system. Trends Immunol 35, 211-218, doi:10.1016/j. it.2014.03.006 (2014).
42. Tussiwand, R., et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502-507, doi:10.1038/nature11531 (2012).
43. Ochiai, K., et al. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat Immunol 13, 300-307, doi:10.1038/ni.2210 (2012).
44. Spooner, C. J., Cheng, J. X., Pujadas, E., Laslo, P., Singh, H. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 31, 576-586, doi:10.1016/j.immuni.2009.07.011 (2009).
45. Livigni, A., et al. Petri Net-Based Graphical and Computational Modelling of Biological Systems. bioRxiv, doi:10.1101/047043 (2016).
46. O'Hara, L., et al. Modelling the Structure and Dynamics of Biological Pathways. PLoS Biol 14, e1002530, doi:10.1371/journal. pbio.1002530 (2016).
47. Li, P., et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543-546, doi:10.1038/nature11530 (2012).
48. Behar, M., Hoffmann, A. Understanding the temporal codes of intra-cellular signals. Curr Opin Genet Dev 20, 684-693, doi:10.1016/j.gde.2010.09.007 (2010).
49. Berghout, J., et al. Irf8-regulated genomic responses drive pathological inflammation during cerebral malaria. PLoS Pathog 9, e1003491, doi:10.1371/journal.ppat.1003491 (2013).
50. Munz, C., et al. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105, 266-273, doi:10.1182/blood-2004-06-2492 (2005).
51. Ratzinger, G., et al. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermalinterstitial or monocyte-derived dendritic cells. J Immunol 173, 2780-2791 (2004).
52. Camps, M., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11, 936-943, doi:10.1038/nm1284 (2005).
53. Schlitzer, A., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983, doi:10.1016/j.immuni.2013.04.011 (2013).
54. Vander Lugt, B., et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol, doi:10.1038/ni.2795 (2013).
55. Gupta, M., et al. IRF8 directs stress-induced autophagy in macrophages and promotes clearance of Listeria monocytogenes. Nature communications 6, 6379, doi:10.1038/ncomms7379 (2015).
56. Akbari, M., et al. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major. J Immunol 192, 2271-2279, doi:10.4049/jimmunol.1301914 (2014).
57. Swindell, W. R., et al. Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sites. Clin Transl Med 4, 13, doi:10.1186/s40169-015-0054-5 (2015).
58. Farh, K. K., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337-343, doi:10.1038/nature13835 (2015).
59. Loriaux, P. M., Tesler, G., Hoffmann, A. Characterizing the relationship between steady state and response using analytical expressions for the steady states of mass action models. PLoS Comput Biol 9, e1002901, doi:10.1371/journal.pcbi.1002901 (2013).
60. Karlebach, G., Shamir, R. Modelling and analysis of gene regulatory networks. Nature reviews. Molecular cell biology 9, 770-780, doi:10.1038/nrm2503 (2008).
61. Werner, S. L., et al. Encoding NF-kappaB temporal control in response to TNF: Distinct roles for the negative regulators IkappaBalpha and A20. Genes Dev 22, 2093-2101, doi:10.1101/gad.1680708 (2008).
62. Shih, V. F., et al. Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen-A nd cytokinereceptor signaling specificity. Proc Natl Acad Sci USA 106, 9619-9624, doi:10.1073/pnas.0812367106 (2009).
63. Werner, S. L., Barken, D., Hoffmann, A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science (New York, N.Y.) 309, 1857-1861, doi:10.1126/science.1113319 (2005).
64. Arisi, I., Cattaneo, A., Rosato, V. Parameter estimate of signal transduction pathways. BMC neuroscience 7 (Suppl 1), S6, doi:10.1186/1471-2202-7-s1-s6 (2006).
65. Bailey, J. E. Complex biology with no parameters. Nature biotechnology 19, 503-504, doi:10.1038/89204 (2001).
66. Papin, J. A., Hunter, T., Palsson, B. O., Subramaniam, S. Reconstruction of cellular signalling networks and analysis of their properties. Nature reviews. Molecular cell biology 6, 99-111, doi:10.1038/nrm1570 (2005).
67. Li, S., Wang, L., Berman, M., Kong, Y. Y., Dorf, M. E. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35, 426-440, doi:10.1016/j.immuni.2011.06.014 (2011).
68. Glass, L., Kauffman, S. A. The logical analysis of continuous, non-linear biochemical control networks. Journal of theoretical biology 39, 103-129 (1973).
69. Peleg, M., Yeh, I., Altman, R. B. Modelling biological processes using workflow and Petri Net models. Bioinformatics (Oxford, England) 18, 825-837 (2002).
70. Bourdon, J., Eveillard, D., Siegel, A. Integrating quantitative knowledge into a qualitative gene regulatory network. PLoS Comput Biol 7, e1002157, doi:10.1371/journal.pcbi.1002157 (2011).
71. Friedlander, T., Prizak, R., Guet, C. C., Barton, N. H., Tkacik, G. Intrinsic limits to gene regulation by global crosstalk. Nature communications 7, 12307, doi:10.1038/ncomms12307 (2016).
72. Csardi, G., Franks, A., Choi, D. S., Airoldi, E. M., Drummond, D. A. Accounting for experimental noise reveals that mRNA levels, amplified by post-transcriptional processes, largely determine steady-state protein levels in yeast. PLoS genetics 11, e1005206, doi:10.1371/journal.pgen.1005206 (2015).
73. Hirsch, E., et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science (New York, N.Y.) 287, 1049-1053 (2000).
74. Rommel, C., Camps, M., Ji, H. PI3K delta and PI3K gamma: Partners in crime in inflammation in rheumatoid arthritis and beyond? Nature reviews. Immunology 7, 191-201, doi:10.1038/nri2036 (2007).
75. Banham-Hall, E., Clatworthy, M. R., Okkenhaug, K. The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases. The open rheumatology journal 6, 245-258, doi:10.2174/1874312901206010245 (2012).
76. Winkler, D. G., et al. PI3K-delta and PI3K-gamma inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chemistry & biology 20, 1364-1374, doi:10.1016/j.chembiol.2013.09.017 (2013).
77. Del Prete, A., et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. The EMBO journal 23, 3505-3515, doi:10.1038/sj.emboj.7600361 (2004).
78. Clark, R. A., et al. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med 4, 117ra117, doi:10.1126/scitranslmed.3003008 (2012).
79. Fauque, P., et al. In vitro fertilization and embryo culture strongly impact the placental transcriptome in the mouse model. PLoS One 5, e9218, doi:10.1371/journal.pone.0009218 (2010).
80. Kim, S. W., Kim, S. J., Langley, R. R., Fidler, I. J. Modulation of the cancer cell transcriptome by culture media formulations and cell density. Int J Oncol 46, 2067-2075, doi:10.3892/ijo.2015.2930 (2015).
81. Shahdadfar, A., Fronsdal, K., Haug, T., Reinholt, F. P., Brinchmann, J. E. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, transcriptome stability. Stem Cells 23, 1357-1366, doi:10.1634/stemcells.2005-0094 (2005).
82. Contoli, M., et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 70, 910-920, doi:10.1111/all.12627 (2015).
83. McCollum, A. M., et al. Molluscum contagiosum in a pediatric American Indian population: Incidence and risk factors. PLoS One 9, e103419, doi:10.1371/journal.pone.0103419 (2014).
84. Borkar, D. S., et al. Association between atopy and herpetic eye disease: Results from the pacific ocular inflammation study. JAMA Ophthalmol 132, 326-331, doi:10.1001/jamaophthalmol.2013.6277 (2014).
85. Seneschal, J., Clark, R. A., Gehad, A., C. M., B.-A., T. S., K. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36, 873-884 (2012).
86. Kim, M., et al. Relay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin. PLoS Pathog 11, e1004812, doi:10.1371/journal.ppat.1004812 (2015).
87. Puttur, F. K., et al. Herpes simplex virus infects skin gamma delta T cells before Langerhans cells and impedes migration of infected Langerhans cells by inducing apoptosis and blocking E-cadherin downregulation. J Immunol 185, 477-487, doi:10.4049/jimmunol.0904106 (2010).
88. Petermann, P., et al. Entry mechanisms of herpes simplex virus 1 into murine epidermis: Involvement of nectin-1 and herpesvirus entry mediator as cellular receptors. J Virol 89, 262-274, doi:10.1128/jvi.02917-14 (2015).